Information processing deficits and nitric oxide signalling in the phencyclidine model of schizophrenia

Psychopharmacology

Volumn 212, Issue 4, 2010, Pages 643-651

  Pålsson, Erik ^a,b   Lowry, John ^a,b   Klamer, Daniel ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Nitric oxide; Nitric oxide synthase; NMDA receptor; Phencyclidine; Prefrontal cortex; Prepulse inhibition; Rat; Schizophrenia; Voltammetry

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; ISOENZYME; N(G) PROPYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENCYCLIDINE;

AMPEROMETRIC BIOSENSOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG TARGETING; HIPPOCAMPUS; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

EID: 78651344094     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1992-7     Document Type: Article

References (56)

1. Adams B, Moghaddam B (1998) Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18:5545-5554
2. Baba H, Suzuki T, Arai H, Emson PC (2004) Expression of nNOS and soluble guanylate cyclase in schizophrenic brain. NeuroReport 15:677-680
3. Behrens MM, Sejnowski TJ (2009) Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex? Neuropharmacology 57:193-200
4. Bernstein HG, Krell D, Braunewell KH, Baumann B, Gundelfinger ED, Diekmann S, Danos P, Bogerts B (2001) Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia. J Neurocytol 30:661-670
5. Bird DC, Bujas-Bobanovic M, Robertson HA, Dursun SM (2001) Lack of phencyclidine-induced effects in mice with reduced neuronal nitric oxide synthase. Psychopharmacology (Berl) 155:299-309
6. Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, Swerdlow NR (2001) Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res 49:171-178
7. Brown FO, Lowry JP (2003) Microelectrochemical sensors for in vivo brain analysis: An investigation of procedures for modifying Pt electrodes using Nafion. Analyst 128:700-705
8. Brown FO, Finnerty NJ, Bolger FB, Millar J, Lowry JP (2005) Calibration of NO sensors for in-vivo voltammetry: Laboratory synthesis of NO and the use of UV-visible spectroscopy for determining stock concentrations. Anal Bioanal Chem 381:964-971
9. Brown FO, Finnerty NJ, Lowry JP (2009) Nitric oxide monitoring in brain extracellular fluid: Characterisation of Nafion-modified Pt electrodes in vitro and in vivo. Analyst 134:2012-2020
10. Bujas-Bobanovic M, Bird DC, Robertson HA, Dursun SM (2000) Blockade of phencyclidine-induced effects by a nitric oxide donor. Br J Pharmacol 130:1005-1012
11. Chaki S, Okuyama S, Ogawa S, Tomisawa K (1998) Regulation of NMDA-induced [3H]dopamine release from rat hippocampal slices through sigma-1 binding sites. Neurochem Int 33:29-34
12. Deutsch SI, Rosse RB, Schwartz BL, Fay-McCarthy M, Rosenberg PB, Fearing K (1997) Methylene blue adjuvant therapy of schizophrenia. Clin Neuropharmacol 20:357-363
13. Fedele E, Marchi M, Raiteri M (2001) In vivo NO/cGMP signalling in the hippocampus. Neurochem Res 26:1069-1078
14. Fejgin K, Palsson E, Wass C, Svensson L, Klamer D (2008) Nitric oxide signaling in the medial prefrontal cortex is involved in the biochemical and behavioral effects of phencyclidine. Neuropsychopharmacology 33:1874-1883
15. Fejgin K, Palsson E, Wass C, Finnerty N, Lowry J, Klamer D (2009) Prefrontal GABA(B) receptor activation attenuates phencyclidineinduced impairments of prepulse inhibition: Involvement of nitric oxide. Neuropsychopharmacology 34:1673-1684
16. Franklin KBJ, Paxinos G (1998) The rat brain in stereotaxic coordinates. Academic Press: New York
17. Garthwaite J (2010) New insight into the functioning of nitric oxidereceptive guanylyl cyclase: Physiological and pharmacological implications. Mol Cell Biochem 334:221-232
18. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade in review. Psychopharmacology (Berl) 156:117-154
19. Goff DC, Cather C, Freudenreich O, Henderson DC, Evins AE, Culhane MA, Walsh JP (2009) A placebo-controlled study of sildenafil effects on cognition in schizophrenia. Psychopharmacology (Berl) 202:411-417
20. Guix FX, Uribesalgo I, Coma M, Munoz FJ (2005) The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol 76:126-152
21. Hall CN, Garthwaite J (2006) Inactivation of nitric oxide by rat cerebellar slices. J Physiol 577:549-567
22. Hall CN, Garthwaite J (2009) What is the real physiological NO concentration in vivo? Nitric Oxide 21:92-103
23. Hall CN, Keynes RG, Garthwaite J (2009) Cytochrome P450 oxidoreductase participates in nitric oxide consumption by rat brain. Biochem J 419:411-418
24. Hernandez L, Auerbach S, Hoebel BG (1988) Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis. Life Sci 42:1713-1723
25. Homayoun H, Moghaddam B (2007) NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 27:11496-11500
26. Jentsch JD, Elsworth JD, Redmond DE Jr, Roth RH (1997) Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: Modulation by the isomers of HA966. J Neurosci 17:1769-1775
27. Johansson C, Jackson DM, Svensson L (1997) Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat. Psychopharmacology (Berl) 131:167-173
28. Klamer D, Engel JA, Svensson L (2001) The nitric oxide synthase inhibitor, L-NAME, block phencyclidine-induced disruption of prepulse inhibition in mice. Psychopharmacology (Berl) 156:182-186
29. Klamer D, Engel JA, Svensson L (2004a) The neuronal selective nitric oxide synthase inhibitor, Nomega-propyl-L-arginine, blocks the effects of phencyclidine on prepulse inhibition and locomotor activity in mice. Eur J Pharmacol 503:103-107
30. Klamer D, Engel JA, Svensson L (2004b) Phencyclidine-induced behaviour in mice prevented by methylene blue. Pharmacol Toxicol 94:65-72
31. Klamer D, Engel JA, Svensson L (2004c) Phencyclidine increases prepulse inhibition of acoustic startle in neuronal nitric oxide synthase deficient mice. The Journal of the European College of Neuropsychopharmacology 14(Supplement 1):36-37
32. Klamer D, Palsson E, Revesz A, Engel JA, Svensson L (2004d) Habituation of acoustic startle is disrupted by psychotomimetic drugs: Differential dependence on dopaminergic and nitric oxide modulatory mechanisms. Psychopharmacology (Berl) 176:440-450
33. Klamer D, Palsson E, Fejgin K, Zhang J, Engel JA, Svensson L (2005a) Activation of a nitric-oxide-sensitive cAMP pathway with phencyclidine: Elevated hippocampal cAMP levels are temporally associated with deficits in prepulse inhibition. Psychopharmacology (Berl) 179:479-488
34. Klamer D, Palsson E, Wass C, Archer T, Engel JA, Svensson L (2005b) Antagonism of the nitric oxide synthase inhibitor, LNAME, of the effects of phencyclidine on latent inhibition in taste aversion conditioning. Behav Brain Res 161:60-68 (Pubitemid 40719770)
35. Kusljic S, van den Buuse M (2004) Functional dissociation between serotonergic pathways in dorsal and ventral hippocampus in psychotomimetic drug-induced locomotor hyperactivity and prepulse inhibition in rats. Eur J Neurosci 20:3424-3432
36. Lopez-Figueroa MO, Day HE, Akil H, Watson SJ (1998) Nitric oxide in the stress axis. Histol Histopathol 13:1243-1252
37. Loscher W, Annies R, Honack D (1991) The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci Lett 128:191-194
38. Lowry JP, O'Neill RD (2005) Neuroanalytical chemistry in vivo using biosensors. In: Grimes CA, Dickey EC (eds) Encyclopedia of sensors. American Scientific Publishers, California, pp 501-524
39. Lowry JP, Boutelle MG, Fillenz M (1997) Measurement of brain tissue oxygen at a carbon past electrode can serve as an index of increases in regional cerebral blood flow. J Neurosci Methods 71:177-182
40. Martin P, Carlsson ML, Hjorth S (1998) Systemic PCP treatment elevates brain extracellular 5-HT: A microdialysis study in awake rats. NeuroReport 9:2985-2988
41. Palsson E, Finnerty N, Fejgin K, Klamer D, Wass C, Svensson L, Lowry J (2009) Increased cortical nitric oxide release after phencyclidine administration. Synapse 63:1083-1088
42. Park DJ, West AR (2009) Regulation of striatal nitric oxide synthesis by local dopamine and glutamate interactions. J Neurochem 111:1457-1465
43. Pepicelli O, Brescia A, Gherzi E, Raiteri M, Fedele E (2004) GABA (A), but not NMDA, receptors modulate in vivo NO-mediated cGMP synthesis in the rat cerebral cortex. Neuropharmacology 46:480-489
44. Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, Wienker T, Topner T, Fritzen S, Walter U, Schmitt A, Fallgatter AJ, Lesch KP (2006) A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 11:286-300
45. Sato M, Hida N, Umezawa Y (2005) Imaging the nanomolar range of nitric oxide with an amplifier-coupled fluorescent indicator in living cells. Proc Natl Acad Sci USA 102:14515-14520
46. Sevgi S, Ozek M, Eroglu L (2006) L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress. Methods Find Exp Clin Pharmacol 28:95-99
47. Steinbusch HWM, De Vente J, Vincent SR (2000) Functional neuroanatomy of the nitric oxide system. In: Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy. Elsevier, Amsterdam
48. Steinert JR, Kopp-Scheinpflug C, Baker C, Challiss RA, Mistry R, Haustein MD, Griffin SJ, Tong H, Graham BP, Forsythe ID (2008) Nitric oxide is a volume transmitter regulating postsynaptic excitability at a glutamatergic synapse. Neuron 60:642-656
49. Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL (2008) Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) 199:331-388
50. Turgeon SM, Lin T, Subramanian M (2007) Subchronic phencyclidine exposure potentiates the behavioral and c-Fos response to stressful stimuli in rats. Pharmacol Biochem Behav 88:73-81
51. Wass C, Archer T, Palsson E, Fejgin K, Alexandersson A, Klamer D, Engel JA, Svensson L (2006) Phencyclidine affects memory in a nitric oxide-dependent manner: Working and reference memory. Behav Brain Res 174:49-55
52. Wass C, Klamer D, Fejgin K, Palsson E (2009) The importance of nitric oxide in social dysfunction. Behav Brain Res 200:113-116
53. Wegener G, Volke V, Rosenberg R (2000) Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. Br J Pharmacol 130:575-580
54. Wiley JL (1998) Nitric oxide synthase inhibitors attenuate phencyclidine-induced disruption of prepulse inhibition. Neuropsychopharmacology 19:86-94
55. Wratten NS, Memoli H, Huang Y, Dulencin AM, Matteson PG, Cornacchia MA, Azaro MA, Messenger J, Hayter JE, Bassett AS, Buyske S, Millonig JH, Vieland VJ, Brzustowicz LM (2009) Identification of a schizophrenia-associated functional noncoding variant in NOS1AP. Am J Psychiatry 166:434-441
56. Vruwink M, Schmidt HH, Weinberg RJ, Burette A (2001) Substance P and nitric oxide signaling in cerebral cortex: Anatomical evidence for reciprocal signaling between two classes of interneurons. J Comp Neurol 441:288-301